$Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed / refractory large B-cell lymphoma$

Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed / refractory large B-cell lymphoma

Not available.Not available.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Haematologica (Roma) 2024-11, Vol.999 (1)
Hauptverfasser:	Falchi, Lorenzo, Hutchings, Martin, Carlo-Stella, Carmelo, Morschhauser, Franck, Dickinson, Michael, Cartron, Guillaume, Khan, Cyrus, Tani, Monica, Martinez-Lopez, Joaquin, Bartlett, Nancy L, Salar, Antonio, Brody, Joshua D, Leppä, Sirpa, Berthier, Aurelien, Kallemeijn, Martine, Relf, James, Tchaleu, Fabiola Bene, Lundberg, Linda, Bachy, Emmanuel
Format:	Artikel
Sprache:	eng
Schlagworte:	Life Sciences
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Not available.Not available.
ISSN:	0390-6078 1592-8721 1592-8721
DOI:	10.3324/haematol.2024.286257